EudraPharm: Difference between revisions

Revision as of 11:16, 17 March 2025

EudraPharm, or the European Union Drug Regulating Authorities Pharmaceutical Database, serves as the centralized database for medicinal products that have received authorization within the European Union. Its comprehensive collection incorporates critical information related to the Summary of Product Characteristics, patient or user package leaflets, and data exhibited on the medicinal labelling.

Overview

The primary objective of the EudraPharm database is to provide transparent and accessible data to the public. In order to ensure the information is both beneficial and easily understood by all users, the database is constructed in a manner that is both comprehensive and user-friendly.

Regulatory Framework

The establishment and functioning of EudraPharm are rooted in EU Regulation 726/2004. This regulation outlines the procedures and criteria for granting medicinal product licenses within the European Union, and it mandates the maintenance of an accessible database of authorized products.

Content and Scope

EudraPharm's focus is largely on products that have undergone the Centralised procedure for licensing. This means that for human medicines, EudraPharm primarily acts as a revamped interface, presenting information previously available via the EPARs (European Public Assessment Reports) section at the European Medicines Agency (EMEA).

Accessibility and Usage

EudraPharm is open to the general public, ensuring that individuals, healthcare professionals, researchers, and policymakers can readily access information about authorized medicinal products within the EU. Given its transparency and comprehensiveness, it plays an integral role in promoting informed decisions related to medicinal usage and policy formulation.

External links

   This article is a health-related stub. You can help WikiMD by expanding it!

@@ Line 39: / Line 39: @@
 {{nt}}
 {{No image}}
+__NOINDEX__